Home Insera Therapeutics Inc.

Insera Therapeutics Inc.

Insera Therapeutics Earns CE Mark Approval for CLEAR Aspiration System

4/8/19: Insera Therapeutics reports this unique aspiration technology offers the ability to vary the vacuum suction pressures and intervals within the safe vacuum suction range up to -98.2 kPa (-29 inHg). A recent study using the CLEAR Aspiration System showed that complete clot ingestion with cyclical aspiration (namely varying the suction pressures) increases first-pass recanalization (namely ability to achieve full vessel re-opening using a single retrieval attempt) and reduces clot fragmentation compared to static aspiration (namely uniform suction pressure).